发展中国家头癌研究的挑战和机遇:火聊天的见解
Aline Lauda Freitas Chaves1, Luiz Paulo Kowalski2, Gustavo Nader Marta3
1DOM Oncologia, Divinópolis, Grupo Oncoclínicas, Belo Horizonte, Brazil.
JCO global oncology
|September 9, 2025
概括
这项研究解决了在资源有限的环境中对头部和部状细胞癌 (HNSCC) 研究的挑战. 它提出了情境敏感的研究和能力建设,以改善全球代表性不足的人口的结果.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 临床研究 临床研究
背景情况:
- 头部和部状细胞癌 (HNSCC) 造成严重的健康负担,特别是在研究基础设施有限的发展中国家.
- 在许多低收入和中等收入国家 (LMICs) 中,获得早期诊断和HNSCC综合护理是有限的.
研究的目的:
- 在资源有限的环境中,综合了解HNSCC临床和转化研究中的挑战和机遇.
- 确定未满足的患者需求,研究障碍,以及推动HNSCC在LMIC研究的战略.
主要方法:
- 一场火聊天,拉丁美洲合作瘤组 (LACOG) - 头部,巴西头癌组 (GBCP) 和国际专家参与其中.
- 讨论的重点是患者需求,研究障碍,务实研究方法和能力建设.
主要成果:
- 关键的挑战包括治疗毒性,晚期呈现,并发症和监管障碍.
- 强调情境敏感,务实研究,能力建设和多学科团队合作至关重要.
- 巴西中心对早期试验做好了准备,并制定了患者招募和合作的策略.
结论:
- 协调的国家研究议程对于巴西和类似的国家至关重要,以有意义地为全球HNSCC研究做出贡献.
- 解决代表性不足的人群的现实问题和促进创新对于推动全球HNSCC护理至关重要.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


